Literature DB >> 28552905

Harnessing class II histone deacetylases in macrophages to combat breast cancer.

Hadar Reichman1, Ariel Munitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28552905      PMCID： PMC5520419          DOI： 10.1038/cmi.2017.32

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  8 in total

1.  Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.

Authors:  Jennifer L Guerriero; Alaba Sotayo; Holly E Ponichtera; Jessica A Castrillon; Alexandra L Pourzia; Sara Schad; Shawn F Johnson; Ruben D Carrasco; Suzan Lazo; Roderick T Bronson; Scott P Davis; Mercedes Lobera; Michael A Nolan; Anthony Letai
Journal:  Nature       Date:  2017-03-08       Impact factor: 49.962

Review 2.  Emerging Roles for Eosinophils in the Tumor Microenvironment.

Authors:  Hadar Reichman; Danielle Karo-Atar; Ariel Munitz
Journal:  Trends Cancer       Date:  2016-11-01

Review 3.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Authors:  Ingunn M Stromnes; Thomas M Schmitt; Aude G Chapuis; Sunil R Hingorani; Philip D Greenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

4.  Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.

Authors:  Mercedes Lobera; Kevin P Madauss; Denise T Pohlhaus; Quentin G Wright; Mark Trocha; Darby R Schmidt; Erkan Baloglu; Ryan P Trump; Martha S Head; Glenn A Hofmann; Monique Murray-Thompson; Benjamin Schwartz; Subhas Chakravorty; Zining Wu; Palwinder K Mander; Laurens Kruidenier; Robert A Reid; William Burkhart; Brandon J Turunen; James X Rong; Craig Wagner; Mary B Moyer; Carrow Wells; Xuan Hong; John T Moore; Jon D Williams; Dulce Soler; Shomir Ghosh; Michael A Nolan
Journal:  Nat Chem Biol       Date:  2013-03-24       Impact factor: 15.040

Review 5.  Neutrophils in cancer: neutral no more.

Authors:  Seth B Coffelt; Max D Wellenstein; Karin E de Visser
Journal:  Nat Rev Cancer       Date:  2016-06-10       Impact factor: 60.716

6.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 8.  Tumor-associated macrophages: from mechanisms to therapy.

Authors:  Roy Noy; Jeffrey W Pollard
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745
  8 in total
  1 in total

Review 1.  Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials.

Authors:  Yang Xu; Ping Li; Yang Liu; Dijia Xin; Wen Lei; Aibin Liang; Weidong Han; Wenbin Qian
Journal:  Cancer Commun (Lond)       Date:  2022-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.